Vir Biotechnology Inc (VIR)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -615,117 | 515,837 | 528,584 | -298,665 | -174,683 |
| Revenue | US$ in thousands | 86,180 | 1,615,800 | 1,095,420 | 76,368 | 8,091 |
| Net profit margin | -713.76% | 31.92% | 48.25% | -391.09% | -2,158.98% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $-615,117K ÷ $86,180K
= -713.76%
Net profit margin is a key financial ratio that indicates the percentage of revenue that translates into net income after all expenses have been deducted. A positive net profit margin indicates profitability, while a negative margin signifies a loss.
Analyzing the net profit margin of Vir Biotechnology Inc over the past five years, we observe significant fluctuations. In 2019, the company reported a substantial negative net profit margin of -2,158.98%, indicating a significant loss relative to revenue. This improved in 2020 but remained negative at -391.09%, showing that expenses still exceeded revenue.
In 2021, there was a notable improvement with a net profit margin of 48.25%, suggesting the company generated a healthy profit compared to revenue. However, the margin dropped in 2022 to 31.92%, indicating a decrease in profitability.
The most recent data for the year ending December 31, 2023, reveals a sharp decline in performance, with a negative net profit margin of -713.76%. This indicates that the company's losses increased significantly compared to revenue for that period.
Overall, the fluctuating trend in Vir Biotechnology Inc's net profit margin over the years suggests inconsistent profitability and potential challenges in managing costs and generating sustainable earnings. Investors and stakeholders may need to closely monitor the company's financial performance and strategies to improve profitability and long-term sustainability.
Peer comparison
Dec 31, 2023